- Home
- APPS vs CTKB Comparison
APPS vs CTKB Comparison
Compare APPS & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APPS | CTKB |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.7M | 541.1M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APPS | CTKB |
|---|---|---|
| Price | $8.50 | $3.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $6.25 | $5.63 |
| AVG Volume (30 Days) | ★ 9.9M | 1.2M |
| Earning Date | 06-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $103,569,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $15.60 | $5.42 |
| Revenue Next Year | $11.34 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 38.55 | 17.67 |
| 52 Week Low | $2.74 | $3.09 |
| 52 Week High | $10.80 | $6.18 |
Technical Indicators
Market Signals| Indicator | APPS | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 39.88 |
| Support Level | $3.45 | $3.71 |
| Resistance Level | $10.80 | $4.49 |
| Average True Range (ATR) | 0.98 | 0.23 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 20.07 | 8.00 |
Price Performance
Historical ComparisonAbout APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.